NCBiotech News

Piedmont Animal Health has teamed up with Wake Forest University's Institute of Regenerative Medicine to develop a novel therapy targeting chronic kidney disease in cats.

Durham ag tech company Plant Response has acquired WISErg, a Redmond, Washington-based startup that has developed technology to capture nutrients from food scraps and turn them into fertilizer.

Bioventus, a Durham-based global orthobiologics company, has acquired Bioness, a California provider of medical technologies that help people regain mobility lost to stroke, traumatic brain injury, multiple sclerosis and osteoarthritis

RTP-based AgBiome has developed three more partnerships -- two that will bring its flagship fungicide to new global markets and the other with The Mosaic Company aiming to develop new products supporting soil health.

Innatrix is already training next-generation scientists how to protect crops using its newly patented platform.

Less pain, much gain: PhotoniCare, an Illinois medical device startup that has set up shop at NCBiotech’s Landing Pad, is shining new light on ear infections with its OtoSight Middle Ear Scope, providing a uniquely important view of the middle ear behind the eardrum.

bluebird bio has hit a major milestone, garnering U.S. Food and Drug Administration approval to market its first product in the U.S., which is also its first cell therapy designed to treat cancer. It's partnered with Bristol Myers on the product launch.

Brii Biosciences is plowing ahead with its clinical development programs after landing a whooping $155 million in funding.

After considering other cities and states, global ag giant Syngenta has decided to keep its North American Crop Protection headquarters in Greensboro, where it will invest $68 million to renovate aging labs and build a new office building to support its 650 employees and 100 contract workers.

Cary-based Chiesi USA has launched its Bronchitol (mannitol) inhalation powder following approval by the FDA, opening treatment options for adults with cystic fibrosis.

Raybow USA, a custom chemical research and development company in the western North Carolina city of Brevard, has announced plans to invest $15.8 million over the next five years in an expansion that will add 74 employees to its current workforce of 26.

Baebies, a Durham company specializing in disorder screening for newborns, has reached a milestone of 10 million tests delivered to labs since its founding in 2014 was bootstrapped by an early loan from the North Carolina Biotechnology Center.

FUJIFILM Corporation today ended a high-stakes economic development drama by announcing that Holly Springs, N.C., is officially its choice for siting a $2 billion biomanufacturing site that will employ 725 over five years.

NC State University and Novozymes have been combining forces to produce more than 2,400 gallons of hand sanitizer to help keep NC State students, faculty and staff safer, as well as people at the NC Museum of Natural Sciences in Raleigh.

Global pharmaceutical giant Merck has confirmed that its flagship Durham vaccine manufacturing facility is gearing up to help competitor Johnson & Johnson produce COVID-19 vaccine.